Stefán Jökull Sveinsson
Nessuna posizione attualmente
Profilo
Stefán Jökull Sveinsson currently works at Nepsone ehf, as Chief Executive Officer and Akthelia ehf, as Director.
Mr. Sveinsson also formerly worked at Actavis Group hf, as Chief Executive Officer-Research & Development from 2002 to 2010, Oculis SA, as Director, the University of Iceland, as Professor from 1991 to 1993, and Actavis, Inc., as Executive Vice President-Research & Development from 2002 to 2013.
Mr. Sveinsson received his graduate degree from Dalhousie University.
Posizioni attive di Stefán Jökull Sveinsson
Società | Posizione | Inizio |
---|---|---|
Akthelia ehf
Akthelia ehf Pharmaceuticals: MajorHealth Technology Akthelia ehf manufactures pharmaceutical products. It focuses on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The company was founded by Eirikur Steingrimsson and Eirikur Steingrímsson and is headquartered in Reykjavik, Iceland. | Director/Board Member | - |
Precedenti posizioni note di Stefán Jökull Sveinsson
Società | Posizione | Fine |
---|---|---|
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Director/Board Member | 04/01/2019 |
Actavis, Inc. /Old/
Actavis, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Actavis, Inc. is engaged in developing, manufacturing and sale of generic pharmaceuticals. They provide a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids. The company is located in Morristown, NJ. | Chief Tech/Sci/R&D Officer | 24/01/2013 |
University of Iceland | Corporate Officer/Principal | 01/01/1993 |
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Chief Tech/Sci/R&D Officer | - |
Formazione di Stefán Jökull Sveinsson
Dalhousie University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
Actavis, Inc. /Old/
Actavis, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Actavis, Inc. is engaged in developing, manufacturing and sale of generic pharmaceuticals. They provide a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids. The company is located in Morristown, NJ. | Health Technology |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Commercial Services |
Akthelia ehf
Akthelia ehf Pharmaceuticals: MajorHealth Technology Akthelia ehf manufactures pharmaceutical products. It focuses on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The company was founded by Eirikur Steingrimsson and Eirikur Steingrímsson and is headquartered in Reykjavik, Iceland. | Health Technology |
- Borsa valori
- Insiders
- Stefán Jökull Sveinsson